About 5 to 10 percent of all cancers are caused by inherited genetic changes passed down from a parent. The remaining 90 to 95 percent arise from DNA damage that accumulates during a person’s lifetime, driven by a mix of random cellular errors, environmental exposures, and lifestyle factors. That ratio surprises many people, but it reflects a crucial distinction: having cancer “run in your family” is not the same as having a hereditary cancer gene.
Inherited vs. Acquired DNA Damage
Every cancer begins with changes to DNA, but those changes can happen in two fundamentally different ways. Inherited mutations are present in every cell of your body from birth because they were carried in the egg or sperm cell that formed you. Acquired mutations happen later in life, in ordinary cells as they divide and copy their DNA billions of times over decades. If a copying error lands in a gene that controls cell growth, and your body’s repair systems don’t catch it, that cell can eventually become cancerous.
Most cancers follow the acquired path. Skin cancer and lung cancer are classic examples: UV radiation damages skin cell DNA over years, and tobacco smoke damages lung cell DNA. These mutations aren’t passed to your children because they don’t exist in your reproductive cells. They’re confined to the tissue where the damage occurred. Even in people with no family history of cancer and no obvious environmental exposure, random DNA copying mistakes during normal cell division account for a significant share of cancer risk. This is why cancer becomes more common with age: the longer cells keep dividing, the more opportunities for errors to pile up.
What Hereditary Cancer Actually Looks Like
When doctors say a cancer is “genetic” in the hereditary sense, they mean a person was born with a mutation in a specific gene that dramatically raises their odds of developing certain cancers. These mutations follow predictable inheritance patterns, and genetic testing can identify them. The most well-known examples involve the BRCA1 and BRCA2 genes. More than 60 percent of women who carry a harmful BRCA1 or BRCA2 change will develop breast cancer in their lifetime. For ovarian cancer, the risk ranges from roughly 39 to 58 percent with a BRCA1 mutation and 13 to 29 percent with a BRCA2 mutation.
Other inherited syndromes carry similarly high risks. People with Li-Fraumeni syndrome, caused by a mutation in the TP53 gene, develop cancer at 24 times the rate of the general population. Carriers of the CDH1 gene mutation face a lifetime risk of diffuse gastric cancer ranging from 25 to 83 percent depending on sex. These are not subtle increases in risk. They represent a fundamentally different starting point, where one critical layer of the body’s cancer defense is already compromised at birth.
Cancers With Higher Hereditary Rates
The 5 to 10 percent figure is an average across all cancer types. Some specific cancers have a much larger hereditary component. Pancreatic cancer stands out: one large study found that roughly 21 percent of pancreatic cancer patients carried an inherited mutation in a cancer predisposition gene. The most commonly affected genes were ATM, BRCA2, CHEK2, and PALB2. Mutations in several of these genes increased pancreatic cancer risk by more than fivefold.
Childhood cancer also has a notable hereditary footprint. About 10 percent of children diagnosed with cancer have an underlying cancer predisposition syndrome. Because children haven’t lived long enough for decades of accumulated DNA damage to drive cancer the way it does in adults, inherited mutations play a proportionally larger role in pediatric cases.
Family History Without a Single Gene
Many people notice cancer clustering in their families without carrying any identifiable high-risk mutation. This is common and doesn’t necessarily point to a hidden hereditary syndrome. Families share more than genes. They share diets, activity levels, environmental exposures, and sometimes habits like smoking or alcohol use. A family with three generations of colon cancer might share a genetic predisposition, or they might share dietary patterns that increase risk, or both.
There’s also a middle ground between a single powerful mutation and pure chance. Hundreds of common genetic variants, each contributing a tiny increase in risk, can add up. Researchers call this polygenic risk. You might inherit a collection of small-effect variants from both parents that nudge your overall cancer risk modestly higher without any single gene being “the cause.” This type of genetic influence is real but much harder to measure, and it blends with lifestyle and environmental factors in ways that are difficult to untangle.
How Lifestyle Interacts With Your Genes
Your DNA is not a fixed blueprint that determines your fate. Genes can be switched on or off by chemical modifications that don’t change the DNA sequence itself. This process, called epigenetics, is heavily influenced by what you eat, whether you exercise, what toxins you’re exposed to, and other environmental factors. One key mechanism involves chemical tags attaching to DNA near tumor suppressor genes. When these genes get silenced by excessive tagging, they can no longer do their job of keeping cell growth in check, effectively mimicking a mutation even though the gene’s code is intact.
This means lifestyle choices can either amplify or dampen the genetic risk you were born with. A person carrying a moderate-risk gene variant who maintains a healthy weight, stays physically active, and avoids tobacco is not in the same position as someone with the same variant who doesn’t. The reverse is also true: even people with no inherited risk can push their cells toward cancer through sustained exposure to carcinogens. Genetics loads the gun, but environment and behavior pull the trigger in most cases.
What Genetic Testing Can and Can’t Tell You
If cancer runs in your family, especially if relatives were diagnosed young or with the same type of cancer, genetic testing can identify whether you carry a high-risk inherited mutation. A positive result for something like BRCA1 or CDH1 opens the door to earlier and more frequent screening, preventive strategies, and in some cases, risk-reducing surgery. It also means your siblings and children may want testing themselves.
A negative result, however, doesn’t mean zero genetic risk. It means you don’t carry the specific mutations the test looks for. The polygenic background risk from hundreds of small-effect variants isn’t captured by standard hereditary cancer panels. And it says nothing about the acquired mutations your cells may accumulate over time. Genetic testing is most useful when there’s a strong family pattern suggesting a specific syndrome, not as a general screening tool for people with average risk.
For the vast majority of people, cancer prevention still comes down to the factors you can control: avoiding tobacco, limiting alcohol, maintaining a healthy weight, staying active, protecting your skin from UV damage, and keeping up with recommended cancer screenings. These won’t eliminate risk, but they target the 90-plus percent of cancer that isn’t inherited.